Founded in 2021 by Joe Betts-LaCroix and initially funded with $180 million from OpenAI CEO Sam Altman, Retro aims to extend ...

For instance, In May 2022, Thermo Fisher and Charles River partnered with robotics company Multiply Labs to advance the automation of cell therapy production, with Thermo Fisher contributing Heracell ...

The findings, led by researchers in the Perelman School of Medicine at the University of Pennsylvania, were published in the New England Journal of Medicine. While CAR T cell therapy—a ...

A phase I study of a next-generation CAR T cell therapy showed a 52 percent complete remission rate for patients with relapsed/refractory lymphoma. A next-generation "armored" CAR T cell therapy ...

IT’S EXPANDING ITS FACILITY IN ROCKVILLE SPECIFICALLY TO WORK ON CELL THERAPY IN SPECIALLY DESIGNED LABS. IT WILL ALLOW ASTRAZENECA TO EXPAND THE AVAILABILITY OF THE PROCEDURE ALL OVER THE WORLD.

A novel study has unveiled a technique that enhances stem cell therapy ... Beyond therapy, the technology may also aid drug testing by creating accurate neural models in labs.

A stem cell–based therapy initially developed at Memorial ... based on very rigorous science beginning in our labs. It might seem unusual for a cancer center to pursue regenerative medicine ...

Perhaps the most exciting lymphoma treatment advances come from targeted therapies that attack specific molecules cancer cells need to survive and multiply ... 6) CAR T-cell therapy, a ...

A new stem cell therapy has repaired blinding damage to the cornea in 93% of patients in an early clinical trial. However, severe injuries, such as those caused by chemical burns or infections ...

On February 13, Allogene Therapeutics published new long-term follow-up data on cemacabtagene ansegedleucel, showing the investigative allogeneic chimeric antigen receptor (CAR) T-cell therapy ...

T-cell therapy with ciltacabtagene autoleucel (cilta-cel) in the phase 3 CARTITUDE-4 trial. Monoclonal T cells from both patients had detectable CAR transgene expression and integration.